ahead estim top bottom line sale ep guidanc rais lower
end reflect neg fx just-clos abaxi acquisit
ep estim consensu ep
guidanc rais lower end higher end
prior reflect slight dilut abaxi neg
impact fx abaxi expect slightli accret rais
ep estim estim review
rais price ep base increas ep estim
improv visibl outlook
sale forecast consensu sale
estim livestock sale
forecast cattl light competit weak dairi companion sale
estim led simparica sale
estim ou livestock sale
forecast companion sale
estim revenu guidanc rais lower end
prior revis reflect addit abaxi juli st off-set
neg fx impact oper growth ex abaxi unchang last
publish estim revenu
gpm estim sg
forecast forecast net interest expens
forecast tax rate estim
share count forecast full year guidanc updat
sg vs prior vs prior
net interest/oth expens vs prior tax rate
approxim vs prior net incom vs prior
dermatolog portfolio apoquel cytopoint sale apoquel
cytopoint estim upsid cytopoint guidanc
dermatolog sale reiter manag also guid blockbust
sale least cytopoint last publish apoquel
cytopoint sale estim apoquel sale
cytopoint sale simparica oral flea tick sale
estim simparica tripl cover flea tick mite intern parasit
heartworm file eu potenti approv launch
pleas see page report import disclosur
rate share outperform base rel attract anim health
market solid outlook top- bottom-lin growth versu market
upsid possibl believ execut prospect move share higher
apoquel cytopoint sale trend
sale compound-annual-growth-rate
ep compound-annual-growth-rate
apoquel cytopoint simparica uptak
apoquel cytopoint simparica sale
greater expect
signific product emerg
new oper restructur
restructur provid greater
influx small new competitor dampen
zoeti inc engag discoveri develop manufactur commerci
anim health medicin vaccin focu livestock companion anim
primari livestock speci cattl beef dairi swine poultri sheep fish
primari companion anim speci dog cat hors zoeti spun
cowen compani
chg total good profit margin intang oper incom expens incom inc/loss non-control share cowen
valuat methodolog primarili base current year forward price-to-earnings multipl
also consid total return/p ratio discount cash flow
competit dynam global potenti regulatori delay reject failur
and/or polit uncertainti emerg market chang tax law outlook
dividend fluctuat foreign exchang rate
risk price includ abil re-suppli apoquel success pipelin
product weather/diseas risk busi success independ compani
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock zoeti secur
author report member author household long posit equiti secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
